ATP Release from Human Airway Epithelial Cells Exposed to Staphylococcus aureus Alpha-Toxin

Airway epithelial cells reduce cytosolic ATP content in response to treatment with S. aureus alpha-toxin (hemolysin A, Hla). This study was undertaken to investigate whether this is due to attenuated ATP generation or to release of ATP from the cytosol and extracellular ATP degradation by ecto-enzymes. Exposure of cells to rHla did result in mitochondrial calcium uptake and a moderate decline in mitochondrial membrane potential, indicating that ATP regeneration may have been attenuated. In addition, ATP may have left the cells through transmembrane pores formed by the toxin or through endogenous release channels (e.g., pannexins) activated by cellular stress imposed on the cells by toxin exposure. Exposure of cells to an alpha-toxin mutant (H35L), which attaches to the host cell membrane but does not form transmembrane pores, did not induce ATP release from the cells. The Hla-mediated ATP-release was completely blocked by IB201, a cyclodextrin-inhibitor of the alpha-toxin pore, but was not at all affected by inhibitors of pannexin channels. These results indicate that, while exposure of cells to rHla may somewhat reduce ATP production and cellular ATP content, a portion of the remaining ATP is released to the extracellular space and degraded by ecto-enzymes. The release of ATP from the cells may occur directly through the transmembrane pores formed by alpha-toxin

ATP Release from Human Airway Epithelial Cells Exposed to Staphylococcus aureus Alpha-Toxin

Airway epithelial cells reduce cytosolic ATP content in response to treatment with S. aureus alpha-toxin (hemolysin A, Hla). This study was undertaken to investigate whether this is due to attenuated ATP generation or to release of ATP from the cytosol and extracellular ATP degradation by ecto-enzymes. Exposure of cells to rHla did result in mitochondrial calcium uptake and a moderate decline in mitochondrial membrane potential, indicating that ATP regeneration may have been attenuated. In addition, ATP may have left the cells through transmembrane pores formed by the toxin or through endogenous release channels (e.g., pannexins) activated by cellular stress imposed on the cells by toxin exposure. Exposure of cells to an alpha-toxin mutant (H35L), which attaches to the host cell membrane but does not form transmembrane pores, did not induce ATP release from the cells. The Hla-mediated ATP-release was completely blocked by IB201, a cyclodextrin-inhibitor of the alpha-toxin pore, but was not at all affected by inhibitors of pannexin channels. These results indicate that, while exposure of cells to rHla may somewhat reduce ATP production and cellular ATP content, a portion of the remaining ATP is released to the extracellular space and degraded by ecto-enzymes. The release of ATP from the cells may occur directly through the transmembrane pores formed by alpha-toxin

sj-docx-1-whe-10.1177_17455057231199051 – Supplemental material for Higher perceived stress during the COVID-19 pandemic increased menstrual dysregulation and menopause symptoms

Supplemental material, sj-docx-1-whe-10.1177_17455057231199051 for Higher perceived stress during the COVID-19 pandemic increased menstrual dysregulation and menopause symptoms by Romina Garcia de leon, Alexandra Baaske, Arianne Y. Albert, Amy Booth, C. Sarai Racey, Shanlea Gordon, Laurie W. Smith, Anna Gottschlich, Manish Sadarangani, Angela Kaida, Gina S. Ogilvie, Lori A. Brotto and Liisa A.M. Galea in Women’s Health</p

sj-docx-2-whe-10.1177_17455057231199051 – Supplemental material for Higher perceived stress during the COVID-19 pandemic increased menstrual dysregulation and menopause symptoms

Supplemental material, sj-docx-2-whe-10.1177_17455057231199051 for Higher perceived stress during the COVID-19 pandemic increased menstrual dysregulation and menopause symptoms by Romina Garcia de leon, Alexandra Baaske, Arianne Y. Albert, Amy Booth, C. Sarai Racey, Shanlea Gordon, Laurie W. Smith, Anna Gottschlich, Manish Sadarangani, Angela Kaida, Gina S. Ogilvie, Lori A. Brotto and Liisa A.M. Galea in Women’s Health</p